SecBot SecBot
144 ·Filed Nov 13, 2026

IRWD

IRONWOOD PHARMACEUTICALS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 9h ago SEC0002061679-26-000003
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine tax-withholding sale by an officer, not a discretionary insider sale. It does not signal a change in management's view of the company. Monitor future Form 4 filings for any discretionary insider selling patterns.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Tammi Gaskins, an officer of Ironwood Pharmaceuticals, filed a Form 144 notice of intent to sell 6,666 shares of Class A Common Stock, with an approximate market value of $32,330. The sale is described as being to cover taxes from the vesting of stock awards. This is a routine insider sale for tax withholding purposes and represents a small fraction of the company's $806M market cap.

Key Facts

  • Tammi Gaskins, an officer, filed Form 144 to sell 6,666 shares of Class A Common Stock.
  • Estimated aggregate market value of the sale is $32,330.10.
  • The sale is intended to cover taxes from the vesting of restricted stock units granted on 12/11/2024.
  • The proposed sale date is 11/16/2026.
  • The shares are held at E*TRADE Securities LLC and will be sold on NASDAQ.

Financial Impact

Sale of 6,666 shares valued at approximately $32,330, which is about 0.004% of the company's $806M market cap.

dilution

Risk Factors

  • No material risks identified from this filing; the sale is small and for tax purposes.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
70% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0002061679-26-000003
Document: 0002061679-26-000003-index.html0002061679-26-000003
Document: 0002061679-26-000003.txt0002061679-26-000003

Track record

13 reports on IRWD

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +20.35% at T+5 after the Nov 5, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $4.88 Now $4.85 −0.51% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Viewing Entry $4.84 Now $4.85 +0.21% settles Dec 15
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $4.81 Now $4.85 +0.83% settles Dec 9
  4. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $4.81 Now $4.85 +0.83% settles Dec 9
  5. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $4.03 Now $4.85 +20.35% settles Dec 4
  6. Oct 28, 202619d ago SC 13G/A Neutral 3/10 Entry $3.61 Now $4.85 +34.35% settles Nov 25
  7. Oct 16, 20264w ago 8-K Neutral 3/10 Entry $3.50 to $4.85 Now $4.85 +38.57% ▲ +38.57% +39.73% vs SPY
  8. Aug 6, 202614w ago 8-K Bullish 7/10 Entry $4.26 to $4.29 Now $4.85 +13.85% ▲ +0.70% +0.10% vs SPY
  9. May 13, 202626w ago 8-K Mixed 6/10 Entry $3.68 to $3.63 Now $4.85 +31.79% ▼ −1.36% −0.75% vs SPY
  10. May 7, 202627w ago 8-K Bullish 7/10 Entry $4.17 to $3.24 Now $4.85 +16.31% ▼ −22.30% −25.44% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 7h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026